Indication
Competact is indicated in the treatment of type 2 diabetes mellitus patients, particularly overweight patients, who are unable to achieve sufficient glycaemic control at their maximally tolerated dose of oral metformin alone.
In other countries
The same active substances on other registers, the same brand first.
National listings
The national registers that list this EU medicine.
- COMPETACT 15 mg/850 mg COMPRIMIDOS RECUBIERTOS CON PELICULASpain · 15 mg + 850 mg · comprimido recubierto con película · Cheplapharm Arzneimittel GmbhSame brand
- Competact 15 MG/850 MG Comprimidos Recubiertos con PeliculaSpain · 15 mg + 850 mg · comprimido recubierto con película · Takeda Pharma A/S · 2 entriesSame brand
- CompetactCroatiaSame brand